News
FDA Expands Evkeeza Approval to Children 1+ with Rare Cholesterol Disorder
Pune, India | October 03, 2025 The U.S. Food and Drug Administration (FDA) has approved Evkeeza® (evinacumab‑dgnb) for children as young as one year diagnosed
Read More